State Board of Administration of Florida Retirement System’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Hold
14,950
﹤0.01% 1797
2025
Q4
$234K Hold
14,950
﹤0.01% 1843
2025
Q3
$111K Hold
14,950
﹤0.01% 2038
2025
Q2
$67.4K Hold
14,950
﹤0.01% 2096
2025
Q1
$69.4K Hold
14,950
﹤0.01% 2083
2024
Q4
$104K Hold
14,950
﹤0.01% 2097
2024
Q3
$79.2K Hold
14,950
﹤0.01% 2163
2024
Q2
$55.9K Buy
14,950
+140
+0.9% +$714 ﹤0.01% 2170
2024
Q1
$115K Sell
14,810
-140
-0.9% -$830 ﹤0.01% 2039
2023
Q4
$84.5K Hold
14,950
﹤0.01% 2274
2023
Q3
$71.6K Buy
14,950
+140
+0.9% +$901 ﹤0.01% 2285
2023
Q2
$101K Hold
14,810
﹤0.01% 2275
2023
Q1
$115K Hold
14,810
﹤0.01% 2123
2022
Q4
$113K Sell
14,810
-320
-2% -$2.67K ﹤0.01% 2187
2022
Q3
$124K Hold
15,130
﹤0.01% 2164
2022
Q2
$146K Buy
+15,130
New +$152K ﹤0.01% 2186

Other funds holding GLUE

State Board of Administration of Florida Retirement System's GLUE Position: Q1 2026 in Review

State Board of Administration of Florida Retirement System held its Monte Rosa Therapeutics (GLUE) position steady in Q1 2026 at 14,950 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

State Board of Administration of Florida Retirement System first reported a position in GLUE in Q2 2022 and has held it in 16 quarters since. 190 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

  • State Board of Administration of Florida Retirement System held 14,950 shares of Monte Rosa Therapeutics worth $246K as of Q1 2026.
  • State Board of Administration of Florida Retirement System left its Monte Rosa Therapeutics share count unchanged in Q1 2026.
  • Monte Rosa Therapeutics made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #1797 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Monte Rosa Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.